Found: 22
Select item for more details and to access through your institution.
The effect of tolcapone on the pharmacokinetics of benserazide.
- Published in:
- European Journal of Neurology, 1999, v. 6, n. 2, p. 211, doi. 10.1111/j.1468-1331.1999.tb00015.x
- By:
- Publication type:
- Article
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently ‘normal’ alanine aminotransferase levels treated with peginterferon α-2a (40KD) plus ribavirin.
- Published in:
- Liver International, 2008, v. 28, n. 1, p. 61, doi. 10.1111/j.1478-3231.2007.01603.x
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 3, p. 122, doi. 10.1067/mcp.2002.121423
- By:
- Publication type:
- Article
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 6, p. 610, doi. 10.1067/mcp.2000.106795
- By:
- Publication type:
- Article
Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 6, p. 646, doi. 10.1016/S0009-9236(98)90088-1
- By:
- Publication type:
- Article
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 3, p. 300, doi. 10.1016/S0009-9236(97)90033-3
- By:
- Publication type:
- Article
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 57, n. 5, p. 508, doi. 10.1016/0009-9236(95)90035-7
- By:
- Publication type:
- Article
<sup>18</sup>F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
- Published in:
- Synapse, 2002, v. 43, n. 3, p. 201, doi. 10.1002/syn.10034
- By:
- Publication type:
- Article
The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2001, v. 57, n. 2, p. 115, doi. 10.1007/s002280100277
- By:
- Publication type:
- Article
Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 6, p. 698, doi. 10.1002/psp4.12780
- By:
- Publication type:
- Article
Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 6, p. 687, doi. 10.1002/psp4.12731
- By:
- Publication type:
- Article
Pediatric Dosing of Ganciclovir and Valganciclovir: How Model‐Based Simulations Can Prevent Underexposure and Potential Treatment Failure.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 3, p. 167, doi. 10.1002/psp4.12363
- By:
- Publication type:
- Article
Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 699, doi. 10.1111/j.1365-2125.2006.02741.x
- By:
- Publication type:
- Article
Pharmacokinetics of ribavirin in patients with hepatitis C virus.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 710, doi. 10.1111/j.1365-2125.2006.02704.x
- By:
- Publication type:
- Article
Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 52, n. 3, p. 255, doi. 10.1046/j.0306-5251.2001.01452.x
- By:
- Publication type:
- Article
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies.
- Published in:
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 1, p. 39, doi. 10.1046/j.1365-2125.2000.00113.x
- By:
- Publication type:
- Article
Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 48, n. 4
- By:
- Publication type:
- Article
COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet®).
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 48, n. 3
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 1, p. 41, doi. 10.1111/j.1365-2125.1997.tb00136.x
- By:
- Publication type:
- Article
A Guide to Rational Dosing of Monoclonal Antibodies.
- Published in:
- Clinical Pharmacokinetics, 2012, v. 51, n. 2, p. 119, doi. 10.2165/11596370-000000000-00000
- By:
- Publication type:
- Article
A novel strategy for physiologically based predictions of human pharmacokinetics.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Lack of Interaction between Tolcapone and Tolbutamide in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 5, p. 544, doi. 10.1177/009127000004000516
- By:
- Publication type:
- Article